In a report released today, David Risinger from SVB Securities maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $53.00. The company's shares closed last Thursday at $50.72. According to TipRanks.com, Risinger is a 3-star analyst with an average return of 4.5% and a 68.4% success rate. Risinger covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Prometheus Biosciences, and Horizon Therapeutics. Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $56.67, representing an 11.5% upside. In a report issued on July 15, Berenberg Bank also maintained a Hold rating on the stock with a $50.
https://www.tipranks.com/news/blurbs/svb-securities-maintains-a-hold-rating-on-pfizer-pfe?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
過去 株価チャート
から 9 2022 まで 10 2022 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 10 2021 まで 10 2022 Pfizerのチャートをもっと見るにはこちらをクリック